Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/22/26 Sumitovant Biopharma Myfembree for Uterine Fibroids Subscribers Only Subscribers Only Subscribers Only
6/22/26 Haisco (002653) HSK39297 for Paroxysmal Nocturnal Hemoglobinuria (PNH) Subscribers Only Subscribers Only Subscribers Only
6/22/26 Haisco (002653) HSK39297 for Paroxysmal Nocturnal Hemoglobinuria (PNH) Subscribers Only Subscribers Only Subscribers Only
6/21/26 MoonLake (MLTX) sonelokimab for Hidradenitis Suppurativa Subscribers Only Subscribers Only Subscribers Only
6/21/26 MoonLake (MLTX) sonelokimab for Hidradenitis Suppurativa Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update